Impact of Antihypertensive Medications on Implant Success: A Retrospective Cohort Study on Monomedicated Patients

Objective: The aim of this study main is to analyze the influence of antihypertensive treatments on the failure and survival rates of dental implants. Methods: Medical records of 586 patients who received a total of 1,814 dental implants between 2012 and 2022 met the inclusion criteria and were retrospectively reviewed. Patients were divided into two groups: a control group comprising 512 systemically healthy patients with 1581 implants, and a group of 74 patients taking only antihypertensive medications who received a total of 233 implants. Implant failure was assessed according to criteria defined by the International Congress of Oral Implantologists. Results: The failure rates were 5.12% in the control group and 1.29% in the antihypertensive group. Statistical analysis revealed that antihypertensive use was associated with a lower risk of implant failure, indicating a favorable impact. Conclusion: The use of antihypertensive drugs appears to have a positive effect on osseointegration and implant survival. Further research is needed to confirm these effects and better understand the impact of drug treatments on implant success.